Additionally, rare protein-damaging missense variation in FGFR3 was the top predictor of osteochondrodysplasia (OR: 61.51, 7.13−12) from analyses in the UK Biobank reported in the AstraZeneca PheWAS Portal. The gene discussed is FGFR3; the disease is osteochondrodysplasia.